Global Arteriovenous Malformations (AVMs) Market – Industry Trends and Forecast to 2030

Arteriovenous Malformations (AVMs) Market Analysis and Size

Arteriovenous malformations (AVMs) are very rare and occur in less than 1 percent of the general population. AVMs are more common in males than in females. Most people with AVMs will never have any problems. However, nearly 12 % of people with AVMs do have some symptoms. According to the studies, less than 4 % of AVMs haemorrhage occurs and death as a direct result of an AVM happens in about 1 % of people with AVMs.

Data Bridge Market Research analyses that the global arteriovenous malformations (AVMs) market which was USD 2,758.27 million in 2022, is expected to reach USD 4,563.64 million by 2030, and is expected to undergo a CAGR of 6.1% during the forecast period of 2023 to 2030. “Medication” dominates the treatment segment of the global arteriovenous malformations (AVMs) market owing to the growing demand for better methods for treatment in patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Arteriovenous Malformations (AVMs) Market Scope and Segmentation

Market Definition

Arteriovenous malformations (AVMs) are an abnormal tangle of a blood vessel that connects arteries and veins and disrupt the normal blood flow and oxygen circulation. When AVMs occur in any part of the body the surrounding tissues may not get enough oxygen and the affected vein and arteries get weaken and ruptured. If AVMs are in the brain and ruptured, it may cause bleeding in the brain which leads to the connection of haemorrhage, stroke, or brain damage. AVMs can occur anywhere in the body but majorly they are found in the brain and spine.

Global Arteriovenous Malformations (AVMs) Market Dynamics

Drivers

• Increasing Prevalence of Arteriovenous Malformations

The rising prevalence of arteriovenous malformations is a significant driver for the market. AVMs are relatively rare, but their occurrence is increasing, leading to a growing patient population in need of diagnosis and treatment.

• Increasing in the Healthcare Expenditure

Rising healthcare expenditure, particularly in developing countries, allows for better access to healthcare facilities, including diagnostics and treatments for AVMs. Increased healthcare spending contributes to the growth of the global arteriovenous malformations (AVMs) market.

Opportunities

• Growing Research and Development

Increased research activities focused on understanding the pathophysiology of AVMs, developing new treatment modalities, and discovering novel therapeutic targets provide opportunities for innovation. Research collaborations, clinical trials, and investments in R&D can drive market growth by introducing new treatment options.

• Rising Demand for Minimally Invasive Procedures

Minimally invasive treatment options, such as endovascular embolization and stereotactic radiosurgery, are gaining popularity due to their reduced invasiveness, shorter recovery times, and lower complication rates compared to traditional surgical approaches. The market can capitalize on the growing demand for these less invasive procedures.

Restraints/Challenges

• Limited Awareness and Diagnosis

A significant restraint for the global arteriovenous malformations (AVMs) market is the lack of awareness and delayed diagnosis of AVMs. Many AVMs are asymptomatic or have non-specific symptoms, leading to under-diagnosis or misdiagnosis. This can result in delayed treatment and hinder market growth.

• High Cost of Treatment

The treatment of AVMs can be costly, especially for complex cases that require multiple interventions or surgeries. The high cost of treatment can limit access to care, particularly in regions with limited healthcare resources or inadequate insurance coverage. Affordability issues can restrain market growth.

This global arteriovenous malformations (AVMs) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global arteriovenous malformations (AVMs) market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

• In August 2021, Siemens Healthineers has launched its advanced medical imaging solutions, including MRI, CT, and interventional imaging system. They have its presence globally and strives to enhance imaging capabilities for accurate AVM diagnosis and treatment planning for AVMs

Global Arteriovenous Malformations (AVMs) Market Scope

The global arteriovenous malformations (AVMs) market is segmented on the basis of type, stages, treatment, end users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• True Arteriovenous Malformation
• Occult or Cryptic
• Cavernous Malformations
• Venous Malformation
• Hemangioma
• Dural Fistula
• Others

Stages

• Stage I (Quiescence)
• Stage II (Expansion)
• Stage III (Destruction)
• Stage IV (Decompensation)
• Others

Treatment

• Diagnosis
• Cerebral Angiography
• Computerized Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Transcranial Doppler Ultrasound
• Others
• Medication
• Anti-Seizures
• Pain Relievers
• Others
• Surgery
• Others

End Users

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Distribution Channel

• Direct Tender
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Global Arteriovenous Malformations (AVMs) Market Regional Analysis/Insights

The global arteriovenous malformations (AVMs) market is analysed and market size insights and trends are provided by country, type, stages, treatment, end users and distribution channel as referenced above.

The countries covered in the global arteriovenous malformations (AVMs) market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa

North America dominates the global arteriovenous malformations (AVMs) market because of the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, increased consumption of neurological drugs for the treatment of neurological disorders.   

Asia-Pacific is expected to witness significant growth in the global arteriovenous malformations (AVMs) market during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for diagnosis and treatment procedures, the large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global arteriovenous malformations (AVMs) market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global arteriovenous malformations (AVMs) market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global arteriovenous malformations (AVMs) market.

Competitive Landscape and Arteriovenous Malformations (AVMs) Market Share Analysis

The global arteriovenous malformations (AVMs) market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the global arteriovenous malformations (AVMs) market.

Some of the major players operating in the global arteriovenous malformations (AVMs) market are:

• Electrical Geodesics Inc. (U.S.)
• Siemens Healthcare (Germany)
• Masimo Corporation (U.S.)
• Esaote (Italy)
• Shimadzu Corporation (Japan)
• Toshiba Medical Systems Corporation (Japan)
• Carestream Health (U.S.)
• Philips Healthcare (Netherlands)
• Pfizer Inc (U.S.)
• Eli Lilly and Company (U.S.)
• Novartis AG (Switzerland)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Eisai Co., Ltd (Japan)

SKU-59290